BNB$660.07-0.41%BRENT$93.51-0.29%BTC$74,474-0.50%COPPER$6.52+0.98%DJI$52,759-1.32%DOGE$0.0821-1.30%DXY98.74-0.16%ETH$2,345-0.32%GOLD$4,531+0.35%NDX$29,213-0.72%SILVER$68.82+1.10%SOL$89.16-0.05%SPX$7,641-0.87%US10Y4.70+0.92%VIX16.01+7.52%BNB$660.07-0.41%BRENT$93.51-0.29%BTC$74,474-0.50%COPPER$6.52+0.98%DJI$52,759-1.32%DOGE$0.0821-1.30%DXY98.74-0.16%ETH$2,345-0.32%GOLD$4,531+0.35%NDX$29,213-0.72%SILVER$68.82+1.10%SOL$89.16-0.05%SPX$7,641-0.87%US10Y4.70+0.92%VIX16.01+7.52%
MoneyMarket365.comReal-time markets + AI-ranked and AI-analyzed financial news
·Confidence 80%

Moderna Reports Positive Phase 3 Results Amid Earnings Season

Key takeaways

  • Moderna announces positive Phase 3 results for its cancer vaccine as Q2 retail earnings are released and Treasury lowers long-term bond rates.
#Earnings#Healthcare#Treasury

Analysis

Moderna announces positive Phase 3 results for its cancer vaccine as Q2 retail earnings are released and Treasury lowers long-term bond rates.

0 likes · 0 dislikes

Comments & Replies

with Google or GitHub to join the discussion.

  • No comments yet be the first to share your view.